Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureShabbir M.H. Alibhai, Anne M. Horgan
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
An aging world: 2001
2001
Unresolved referenced work
2003
Clinical practice. Current approaches to cervical-cancer screening
10.1056/nejm200105243442107 · 2001
Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data
10.1370/afm.118 · 2004
The influence of health status, age, and race on screening mammography in elderly women
10.1001/archinte.165.18.2083 · 2005
Unresolved referenced work
Kept as external metadata until matched
Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force
10.7326/0003-4819-137-5_part_1-200209030-00012 · 2002
Efficacy of screening mammography. A meta-analysis
10.1001/jama.1995.03520260071035 · 1995
Randomized trial of breast self-examination in Shanghai: final results
10.1093/jnci/94.19.1445 · 2002
Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?
datacite
Confidence 0%
2001
The contribution of clinical breast examination to the accuracy of breast screening
10.1093/jnci/djp241 · 2009
Effect of age, breast density, and family history on the sensitivity of first screening mammography
10.1001/jama.1996.03540010035027 · 1996
Weighing the benefits and burdens of mammography screening among women age 80 years or older
10.1200/jco.2008.19.9877 · 2009
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness
10.1001/jama.282.22.2156 · 1999
Positive predictive value of screening mammography by age and family history of breast cancer
10.1001/jama.1993.03510200050031 · 1993
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
10.1016/s0140-6736(02)08020-0 · 2002
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up
10.1016/s0033-8389(05)70191-3 · 2000
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms
10.7326/0003-4819-151-10-200911170-00010 · 2009
The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force
10.7326/0003-4819-139-10-200311180-00011 · 2003
Detection of ductal carcinoma in situ in women undergoing screening mammography
10.1093/jnci/94.20.1546 · 2002
Cancer statistics, 2009
10.3322/caac.20006 · 2009
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection
2001
Unresolved referenced work
Kept as external metadata until matched
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
10.3322/canjclin.52.6.342 · 2002
Cancer screening in theory and in practice
10.1200/jco.2005.06.107 · 2005
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
10.1002/ijc.21955 · 2006
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies
10.1016/j.ygyno.2006.08.053 · 2007
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer
10.1056/nejmoa071430 · 2007
Management of women who test positive for high-risk types of human papillomavirus: the HART study
10.1016/s0140-6736(03)14955-0 · 2003
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
10.1093/jnci/djh037 · 2004
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
10.1016/s1470-2045(09)70360-2 · 2010
Unresolved referenced work
1998
Primary care of elderly women: is Pap smear screening necessary?
1985
Screening mammography and Pap tests among older American women 1996–2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD)
10.1370/afm.54 · 2003
Papanicolaou smear screening and cervical cancer. What can you expect?
10.1001/jama.1984.03350110023023 · 1984
Benefits and costs of using HPV testing to screen for cervical cancer
10.1001/jama.287.18.2372 · 2002
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
10.1056/nejm199305133281901 · 1993
Randomised study of screening for colorectal cancer with faecal-occult-blood test
10.1016/s0140-6736(96)03430-7 · 1996
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
10.1016/s0140-6736(96)03386-7 · 1996
Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study
10.1053/j.gastro.2004.02.018 · 2004
Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy
10.1001/jama.295.20.2357 · doi-reference
Risk of perforation from a colonoscopy in adults: a large population-based study
10.1016/j.gie.2008.09.008 · doi-reference
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice
10.1053/j.gastro.2008.08.058 · doi-reference
Complications of colonoscopy in an integrated health care delivery system
10.7326/0003-4819-145-12-200612190-00004 · doi-reference
Protection by endoscopy against death from colorectal cancer. A case-control study among veterans
10.1001/archinte.1995.00430160065007 · doi-reference
Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force
10.7326/0003-4819-149-9-200811040-00245 · doi-reference
Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study
10.1002/ijc.2910610406 · doi-reference
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study
10.1093/jnci/95.3.230 · doi-reference
Colorectal cancer screening. Randomised trials of flexible sigmoidoscopy
10.1136/bmj.c4618 · doi-reference
Breast screening in the emerging world: high prevalence of breast cancer in Cairo
10.1016/j.breast.2005.07.002 · doi-reference
Outcome of screening by clinical examination of the breast in a trial in the Philippines
10.1002/ijc.21343 · doi-reference
recommendations and rationale
10.7326/0003-4819-137-5_part_1-200209030-00011 · doi-reference
Edinburgh trial of screening for breast cancer: mortality at seven years
10.1016/0140-6736(90)90066-e · doi-reference
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years
10.1093/jnci/92.18.1490 · doi-reference
The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years
10.7326/0003-4819-137-5_part_1-200209030-00005 · doi-reference
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial
10.1016/s0140-6736(06)69834-6 · doi-reference
The Gothenburg Breast Screening Trial
10.1002/cncr.11361 · doi-reference
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening
10.1200/jco.2009.22.7041 · doi-reference
Development and validation of a prognostic index for 4-year mortality in older adults
10.1001/jama.295.7.801 · doi-reference
Impact of age and comorbidity on colorectal cancer screening among older veterans
10.7326/0003-4819-150-7-200904070-00006 · doi-reference
Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization
10.1001/jama.285.23.2987 · doi-reference
Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression
10.1001/archpsyc.59.11.1046 · doi-reference
Risk factors for 5-year mortality in older adults
10.1001/jama.279.8.585 · doi-reference
Cancer screening in elderly patients: a framework for individualized decision making
10.1001/jama.285.21.2750 · doi-reference
Prognostic importance of comorbidity in a hospital-based cancer registry
10.1001/jama.291.20.2441 · doi-reference
American Cancer Society Guidelines for the Early Detection of Cancer, 2005
10.3322/canjclin.55.1.31 · doi-reference
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement
10.7326/0003-4819-149-3-200808050-00008 · doi-reference
Screening for prostate cancer
10.1016/s0140-6736(03)12890-5 · doi-reference
Lead time associated with screening for prostate cancer
10.1002/ijc.11554 · doi-reference
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer
10.1093/jnci/95.12.868 · doi-reference
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
10.1001/jama.294.1.66 · doi-reference
Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force
10.7326/0003-4819-137-11-200212030-00014 · doi-reference
The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis
10.1093/fampra/16.6.621 · doi-reference
American Cancer Society guideline for the early detection of prostate cancer: update 2010
10.3322/caac.20066 · doi-reference
Screening for prostate cancer–the controversy that refuses to die
10.1056/nejme0901166 · doi-reference
Screening and prostate-cancer mortality in a randomized European study
10.1056/nejmoa0810084 · doi-reference
Mortality results from a randomized prostate-cancer screening trial
10.1056/nejmoa0810696 · doi-reference
Radical prostatectomy versus watchful waiting in early prostate cancer
10.1056/nejmoa043739 · doi-reference
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends
10.1093/jnci/94.13.981 · doi-reference
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement
10.7326/0003-4819-149-9-200811040-00243 · doi-reference